Company Filing History:
Years Active: 2009
Title: Tommi Nyrönen: Innovator in Vascular Adhesion Protein Research
Introduction
Tommi Nyrönen is a notable inventor based in Helsinki, Finland. He has made significant contributions to the field of vascular adhesion proteins, particularly through his innovative research and patenting activities. His work has implications for medical science, especially in the identification and design of inhibitors.
Latest Patents
Tommi Nyrönen holds a patent for "Crystalline VAP-1 and uses thereof." This invention relates to crystalline vascular adhesion protein-1 (VAP-1) and focuses on methods for utilizing structural information of crystalline human VAP-1 for ligand and/or inhibitor identification, design, and production. The patent also includes screening assays for the detection of these inhibitors, showcasing the potential for advancements in therapeutic applications.
Career Highlights
Throughout his career, Tommi has worked with prominent companies in the healthcare sector. He has been associated with Biotie Therapies Corporation and Abbott Healthcare Products B.V. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Tommi has collaborated with notable professionals such as Tiina Annamaria Salminen and Tomi Airenne. These partnerships have enriched his research and expanded the impact of his inventions.
Conclusion
Tommi Nyrönen is a distinguished inventor whose work on vascular adhesion proteins has the potential to influence medical research and treatment. His patent on crystalline VAP-1 exemplifies his innovative approach to solving complex biological challenges.